Your browser doesn't support javascript.
loading
Idelalisib in relapsed/refractory diffuse large B-cell lymphoma: results from a Nordic Lymphoma Group phase II trial.
Fjordén, Karin; Ekberg, Sara; Kuric, Nevzeta; Smedby, Karin E; Lagerlöf, Ingemar; Larsen, Thomas S; Jørgensen, Judit M; de Nully Brown, Peter; Jerkeman, Mats.
Afiliação
  • Fjordén K; Department of Oncology, Lund University, Skane University Hospital, Lund, Sweden.
  • Ekberg S; Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden.
  • Kuric N; Department of Hematology, Halmstad Hospital, Halmstad, Sweden.
  • Smedby KE; Department of Medicine Solna, Division of Hematology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
  • Lagerlöf I; Division of Drug Research, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden.
  • Larsen TS; Department of Haematology, Odense University Hospital, Odense, Denmark.
  • Jørgensen JM; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • de Nully Brown P; Department of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Jerkeman M; Department of Oncology, Lund University, Skane University Hospital, Lund, Sweden.
Br J Haematol ; 196(2): 437-440, 2022 01.
Article em En | MEDLINE | ID: mdl-34435356
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Purinas / Linfoma Difuso de Grandes Células B / Quinazolinonas / Terapia de Alvo Molecular / Inibidores de Fosfoinositídeo-3 Quinase Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Eixos temáticos: Pesquisa_clinica Base de dados: MEDLINE Assunto principal: Purinas / Linfoma Difuso de Grandes Células B / Quinazolinonas / Terapia de Alvo Molecular / Inibidores de Fosfoinositídeo-3 Quinase Tipo de estudo: Diagnostic_studies / Etiology_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article